Skip to main content
Clinical Trials/NCT03448133
NCT03448133
Withdrawn
Not Applicable

Repetitive Transcranial Magnetic Stimulation for the Treatment of Primary Progressive Aphasia: A Randomized Controlled Tria

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aphasia, Primary Progressive
Sponsor
Peking Union Medical College Hospital
Primary Endpoint
Syntax comprehension Part of Bilingual Aphasia Battery( Standard modern Chinese version)
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The primary progressive aphasia (PPA) is a neurodegenerative condition characterized by a gradual, irreversible decline of language function (Mesulam, 2001). There are no known treatments for PPA so far. The relentless progression of PPA symptoms eventually leads to a profound impairment in communication ability and, ultimately, to more generalized deficits of cognition. Some cases and small studies reported that Transcranial Magnetic Stimulation (TMS), one of the non-invasive neuromodulation tech, can be employed to facilitate language production and improve the language ability in patients with PPA. Herein we will explore the tolerance and efficacy of TMS for the treatment of PPA by the randomized controlled trial .Meanwhile the functional MRI tech will be used to investigate the neural network changing in the procedure

Registry
clinicaltrials.gov
Start Date
March 1, 2018
End Date
December 31, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All participants had also been evaluated previously by a behavioral neurologist at the Peking Union Medical College Hospital and had been clinically diagnosed with a variant of PPA.

Exclusion Criteria

  • Scored below 15 on the mini-mental state exam (MMSE) due to concerns that global cognitive impairment might preclude their ability to follow the directions and interfere with task performance.
  • Had a history of seizures or unexplained loss of consciousness, pregnancy, surgical breach of the skull, or any other medical or surgical contraindication to receiving noninvasive brain stimulation.
  • Is unable to complete the treatment and evaluations

Outcomes

Primary Outcomes

Syntax comprehension Part of Bilingual Aphasia Battery( Standard modern Chinese version)

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the grammar ability

Boston naming test evaluation

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the language production

Western Aphasia Battery(WAB) Speech fluency

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the language production

Repetition Part of WAB

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the repetition ability

Word recognition Part of WAB

Time Frame: One month(just after 20 times rTMS treatment)

Assessment of the reading

Secondary Outcomes

  • fMRI parameters(strength, efficiency, clustering coefficient, and characteristic path length)(One month(just after 20 times rTMS treatment))

Similar Trials